Related references
Note: Only part of the references are listed.A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment
Yamaguchi Koichi et al.
MODERN RHEUMATOLOGY (2017)
Cancer Risk in Dermatomyositis: A Meta-Analysis of Cohort Studies
Jeannette M. Olazagasti et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2015)
Interstitial lung disease in anti-synthetase syndrome: Initial and follow-up CT findings
Marie-Pierre Debray et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis
David F. Fiorentino et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy
Vidya Limaye et al.
MUSCLE & NERVE (2015)
Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease
Helena Andersson et al.
RHEUMATOLOGY (2015)
Cancer-Induced Autoimmunity in the Rheumatic Diseases
Ami A. Shah et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Inflammatory myopathy with anti-SRP antibodies: case series of a South Australian cohort
Sajini K. Basnayake et al.
CLINICAL RHEUMATOLOGY (2015)
The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis
T. Kurita et al.
LUPUS (2015)
Interstitial Lung Disease in Undifferentiated Forms of Connective Tissue Disease
Aryeh Fischer et al.
ARTHRITIS CARE & RESEARCH (2015)
Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients
Rohit Aggarwal et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort
Levente Bodoki et al.
AUTOIMMUNITY REVIEWS (2014)
Establishment of an ELISA to detect anti-glycyl-tRNA synthetase antibody (anti-EJ), a serological marker of dermatomyositis/polymyositis and interstitial lung disease
Hiroaki Hane et al.
CLINICA CHIMICA ACTA (2014)
The Evolving Spectrum of Polymyositis and Dermatomyositis-Moving Towards Clinicoserological Syndromes: A Critical Review
Sarah Tansley et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2014)
Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances
Robert W. Hallowell et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathy
Frank Schneider et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease
Shinji Sato et al.
Modern Rheumatology (2014)
Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients
Eun Ha Kang et al.
MODERN RHEUMATOLOGY (2014)
The Multicenter Study of a New Assay for Simultaneous Detection of Multiple Anti-Aminoacyl-tRNA Synthetases in Myositis and Interstitial Pneumonia
Ran Nakashima et al.
PLOS ONE (2014)
Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type
C. Johnson et al.
RESPIRATORY MEDICINE (2014)
Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation
Rohit Aggarwal et al.
RHEUMATOLOGY (2014)
Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset
Sarah L. Tansley et al.
RHEUMATOLOGY (2014)
Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population
Leonore Unger et al.
RHEUMATOLOGY (2014)
Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody
Alfredo Guillen-Del Castillo et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Pulmonary Manifestations of Polymyositis/Dermatomyositis
Robert W. Hallowell et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Autoantibodies to RuvBL1 and RuvBL2: A Novel Systemic Sclerosis-Related Antibody Associated With Diffuse Cutaneous and Skeletal Muscle Involvement
Kenzou Kaji et al.
ARTHRITIS CARE & RESEARCH (2014)
Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies
Laurent Drouot et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study
Sarah L. Tansley et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Identification of Clinical Features and Autoantibodies Associated With Calcinosis in Dermatomyositis
Antonia Valenzuela et al.
JAMA DERMATOLOGY (2014)
Clinical and Serologic Correlates of Anti-PM/Scl Antibodies in Systemic Sclerosis A Multicenter Study of 763 Patients
Julie D'Aoust et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Predictors of Clinical Improvement in Rituximab-Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis
Rohit Aggarwal et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort
Manabu Fujimoto et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ
David F. Fiorentino et al.
ARTHRITIS AND RHEUMATISM (2013)
Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis A Randomized, Placebo-Phase Trial
Chester V. Oddis et al.
ARTHRITIS AND RHEUMATISM (2013)
Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients
Yoshinao Muro et al.
AUTOIMMUNITY (2013)
A New ELISA for Dermatomyositis Autoantibodies: Rapid Introduction of Autoantigen cDNA to Recombinant Assays for Autoantibody Measurement
Yoshinao Muro et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis
Yoshinao Muro et al.
CLINICAL RHEUMATOLOGY (2013)
Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome
I. Marie et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2013)
Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature
Linda Nalotto et al.
IMMUNOLOGIC RESEARCH (2013)
Cyclosporine in Anti-Jo1-positive Patients with Corticosteroid-refractory Interstitial Lung Disease
Lorenzo Cavagna et al.
JOURNAL OF RHEUMATOLOGY (2013)
Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease
Aryeh Fischer et al.
JOURNAL OF RHEUMATOLOGY (2013)
The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
Lisa G. Rider et al.
MEDICINE (2013)
Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome
Yasuhito Hamaguchi et al.
PLOS ONE (2013)
Outcome of anti-PL12 positive patients with antisynthetase syndrome
Isabelle Marie et al.
PRESSE MEDICALE (2013)
Anti-Melanoma Differentiation-Associated Protein 5-Associated Dermatomyositis: Expanding the Clinical Spectrum
John C. Hall et al.
ARTHRITIS CARE & RESEARCH (2013)
Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara
Marcelo H. Petri et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays
Moises Labrador-Horrillo et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy
Yuki Ichimura et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Myopathy Associated With Antibodies to Signal Recognition Particle Disease Progression and Neurological Outcome
Shigeaki Suzuki et al.
ARCHIVES OF NEUROLOGY (2012)
Antibody Levels Correlate With Creatine Kinase Levels and Strength in Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Associated Autoimmune Myopathy
Jessie L. Werner et al.
ARTHRITIS AND RHEUMATISM (2012)
Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins
Manabu Fujimoto et al.
ARTHRITIS AND RHEUMATISM (2012)
Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: A systematic review and meta-analysis
Ernesto Trallero-Araguas et al.
ARTHRITIS AND RHEUMATISM (2012)
Comparison of long-term outcome between anti-Jo1-and anti-PL7/PL12 positive patients with antisynthetase syndrome
I. Marie et al.
AUTOIMMUNITY REVIEWS (2012)
Response of Mucocutaneous Lesions to Rituximab in a Case of Melanoma Differentiation Antigen 5-Related Dermatomyositis
Aurelie Clottu et al.
DERMATOLOGY (2012)
Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort
Elena Tarricone et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Autoantibodies to nuclear matrix protein 2/MJ in adult-onset dermatomyositis with severe calcinosis
Kazumitsu Sugiura et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
A Novel Dermato-Pulmonary Syndrome Associated With MDA-5 Antibodies Report of 2 Cases and Review of the Literature
Neal F. Chaisson et al.
MEDICINE (2012)
Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome
I. Marie et al.
RESPIRATORY MEDICINE (2012)
Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM/interstitial lung disease during disease remission
Yoshinao Muro et al.
RHEUMATOLOGY (2012)
Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis
Takahisa Gono et al.
RHEUMATOLOGY (2012)
Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2
Asuka Ishikawa et al.
RHEUMATOLOGY (2012)
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis
Angela Ceribelli et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Autoantibodies Against 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase in Patients With Statin-Associated Autoimmune Myopathy
Andrew L. Mammen et al.
ARTHRITIS AND RHEUMATISM (2011)
Anti-Melanoma Differentiation-Associated Gene 5 Antibody is a Diagnostic and Predictive Marker for Interstitial Lung Diseases Associated with Juvenile Dermatomyositis
Ichiro Kobayashi et al.
JOURNAL OF PEDIATRICS (2011)
Safety and Efficacy of Rituximab in Severe Juvenile Dermatomyositis: Results from 9 Patients from the French Autoimmunity and Rituximab Registry
Brigitte Bader-Meunier et al.
JOURNAL OF RHEUMATOLOGY (2011)
The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study
David Fiorentino et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias
Kizuku Watanabe et al.
RESPIRATORY MEDICINE (2011)
Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry
Marion Couderc et al.
RHEUMATOLOGY (2011)
Rituximab treatment in patients with refractory inflammatory myopathies
Elien A. M. Mahler et al.
RHEUMATOLOGY (2011)
A Novel Autoantibody Recognizing 200-kd and 100-kd Proteins Is Associated With an Immune-Mediated Necrotizing Myopathy
Lisa Christopher-Stine et al.
ARTHRITIS AND RHEUMATISM (2010)
Malignancy and myositis: novel autoantibodies and new insights
Albert Selva-O'Callaghan et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Interstitial Lung Disease Associated with Anti-PM/Scl or Anti-Aminoacyl-tRNA Synthetase Autoantibodies: A Similar Condition?
Jean-Christophe Lega et al.
JOURNAL OF RHEUMATOLOGY (2010)
Cancer-Associated Myositis and Anti-p155 Autoantibody in a Series of 85 Patients With Idiopathic Inflammatory Myopathy
Ernesto Trallero-Araguas et al.
MEDICINE (2010)
The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody
Ran Nakashima et al.
RHEUMATOLOGY (2010)
Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis
Takahisa Gono et al.
RHEUMATOLOGY (2010)
Mycophenolate Mofetil for Interstitial Lung Disease in Dermatomyositis
Pamela A. Morganroth et al.
ARTHRITIS CARE & RESEARCH (2010)
Rituximab Therapy for Myopathy Associated With Anti-Signal Recognition Particle Antibodies: A Case Series
Ritu Valiyil et al.
ARTHRITIS CARE & RESEARCH (2010)
Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis
Z. E. Betteridge et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Ultraviolet Radiation Intensity Predicts the Relative Distribution of Dermatomyositis and Anti-Mi-2 Autoantibodies in Women
Lori A. Love et al.
ARTHRITIS AND RHEUMATISM (2009)
Anti-U3 RNP Autoantibodies in Systemic Sclerosis
Rohit Aggarwal et al.
ARTHRITIS AND RHEUMATISM (2009)
RNA Helicase Encoded by Melanoma Differentiation-Associated Gene 5 Is a Major Autoantigen in Patients With Clinically Amyopathic Dermatomyositis Association With Rapidly Progressive Interstitial Lung Disease
Shinji Sato et al.
ARTHRITIS AND RHEUMATISM (2009)
Autoantibodies to a 140-kd Protein in Juvenile Dermatomyositis Are Associated With Calcinosis
H. Gunawardena et al.
ARTHRITIS AND RHEUMATISM (2009)
Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies
Johan Ronnelid et al.
AUTOIMMUNITY REVIEWS (2009)
Clinical Profile of Anti-PL-12 Autoantibody Cohort Study and Review of the Literature
Meena Kalluri et al.
CHEST (2009)
Clinical and Serologic Characterization of an Argentine Pediatric Myositis Cohort: Identification of a Novel Autoantibody (anti-MJ) to a 142-kDa Protein
Graciela Espada et al.
JOURNAL OF RHEUMATOLOGY (2009)
Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression
Harsha Gunawardena et al.
RHEUMATOLOGY (2009)
Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients
Katharina Hanke et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity
April Bingham et al.
MEDICINE (2008)
Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis
H. Gunawardena et al.
RHEUMATOLOGY (2008)
The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis
Hector Chinoy et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy
Kerry B. Stone et al.
ARTHRITIS AND RHEUMATISM (2007)
Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis
Y. Yamasaki et al.
RHEUMATOLOGY (2007)
Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy
K. Kaji et al.
RHEUMATOLOGY (2007)
Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy
G. J. D. Hengstman et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
A novel autoantibody to a 155-kd protein is associated with dermatomyositis
Ira N. Targoff et al.
ARTHRITIS AND RHEUMATISM (2006)
Treatment of antisynthetase-associated interstitial lung disease with tacrolimus
MR Wilkes et al.
ARTHRITIS AND RHEUMATISM (2005)
Autoantibodies in systemic sclerosis
VD Steen
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis
S Sato et al.
ARTHRITIS AND RHEUMATISM (2005)
Rituximab in the treatment of dermatomyositism - An opel-label pilot study
TD Levine
ARTHRITIS AND RHEUMATISM (2005)
Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease
S Okada et al.
ARTHRITIS AND RHEUMATISM (2003)
Myopathy with antibodies to the signal recognition particle: clinical and pathological features
T Miller et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
ACC/AHA/NHLBI clinical advisory on the use and safety of statins
RC Pasternak et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Clinical and serological characteristics of 125 Dutch myositis patients - Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies
GJD Hengstman et al.
JOURNAL OF NEUROLOGY (2002)
Anti-fibrillarin antibodies in systemic sclerosis
VJ Tormey et al.
RHEUMATOLOGY (2001)
Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis
F Tanaka et al.
INTERNAL MEDICINE (2000)
Share Paper
